Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             40 results found
no title author magazine year volume issue page(s) type
1 Absence of A673T variant in APP gene indicates an alternative protective mechanism contributing to longevity in Chinese individuals Liu, Yao-Wen

35 4 p. 935.e11-935.e12
article
2 Aging is associated with changes in the neural circuits underlying empathy Chen, Yao-Chu

35 4 p. 827-836
article
3 Apolipoprotein E genotype influences spatial distribution of cerebral microbleeds Loehrer, Elizabeth

35 4 p. 899-905
article
4 A role for the neurexin–neuroligin complex in Alzheimer's disease Sindi, Ikhlas A.

35 4 p. 746-756
article
5 Cardiovascular disease contributes to Alzheimer's disease: evidence from large-scale genome-wide association studies Liu, Guiyou

35 4 p. 786-792
article
6 Clinicogenetic study of GBA mutations in patients with familial Parkinson's disease Li, Yuanzhe

35 4 p. 935.e3-935.e8
article
7 Contents
35 4 p. OBC
article
8 Contents continued
35 4 p. 938-939
article
9 Copper pathology in vulnerable brain regions in Parkinson's disease Davies, Katherine M.

35 4 p. 858-866
article
10 C9orf72 repeat expansions are restricted to the ALS-FTD spectrum Ticozzi, Nicola

35 4 p. 936.e13-936.e17
article
11 Corticosteroid treatment of Alzheimer's disease: is S100A9/Mrp14 a key target? Kametani, Fuyuki

35 4 p. e11-e12
article
12 Disentangling the effects of age and APOE on neuropathology and late life cognitive decline Yu, Lei

35 4 p. 819-826
article
13 DNAJ mutations are rare in Chinese Parkinson's disease patients and controls Foo, Jia Nee

35 4 p. 935.e1-935.e2
article
14 Editorial Advisory Board
35 4 p. IFC
article
15 Epigenetically regulated microRNAs in Alzheimer's disease Van den Hove, Daniel L.

35 4 p. 731-745
article
16 Evaluating noncoding nucleotide repeat expansions in amyotrophic lateral sclerosis Figley, Matthew D.

35 4 p. 936.e1-936.e4
article
17 Evaluation of late-onset Alzheimer disease genetic susceptibility risks in a Canadian population Omoumi, Ardeshir

35 4 p. 936.e5-936.e12
article
18 Functional connectivity and graph theory in preclinical Alzheimer's disease Brier, Matthew R.

35 4 p. 757-768
article
19 Genetic and biochemical markers in patients with Alzheimer's disease support a concerted systemic iron homeostasis dysregulation Crespo, Ângela C.

35 4 p. 777-785
article
20 Genetic variation in PICALM and Alzheimer's disease risk in Han Chinese Jiang, Teng

35 4 p. 934.e1-934.e3
article
21 Heritability of brain volumes in older adults: the Older Australian Twins Study Batouli, Seyed Amir Hossein

35 4 p. 937.e5-937.e18
article
22 Heterozygous TREM2 mutations in frontotemporal dementia Borroni, Barbara

35 4 p. 934.e7-934.e10
article
23 hnRNPA2B1 and hnRNPA1 mutations are rare in patients with “multisystem proteinopathy” and frontotemporal lobar degeneration phenotypes Le Ber, Isabelle

35 4 p. 934.e5-934.e6
article
24 Human superoxide dismutase 1 overexpression in motor neurons of Caenorhabditis elegans causes axon guidance defect and neurodegeneration Li, Jia

35 4 p. 837-846
article
25 Identification of C9orf72 repeat expansions in patients with amyotrophic lateral sclerosis and frontotemporal dementia in mainland China Jiao, Bin

35 4 p. 936.e19-936.e22
article
26 Increased pro–nerve growth factor and decreased brain-derived neurotrophic factor in non–Alzheimer's disease tauopathies Belrose, Jillian C.

35 4 p. 926-933
article
27 Management of the aging risk factor for Parkinson's disease Phillipson, Oliver T.

35 4 p. 847-857
article
28 Markers of cholesterol transport are associated with amyloid deposition in the brain Hughes, Timothy M.

35 4 p. 802-807
article
29 Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition Adler, Brittany L.

35 4 p. 793-801
article
30 Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size Yu, Peng

35 4 p. 808-818
article
31 Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice Turner, Bradley J.

35 4 p. 906-915
article
32 Pathogenic effects of amyotrophic lateral sclerosis-linked mutation in D-amino acid oxidase are mediated by D-serine Paul, Praveen

35 4 p. 876-885
article
33 PGRN haploinsufficiency increased Wnt5a signaling in peripheral cells from frontotemporal lobar degeneration-progranulin mutation carriers Alquézar, Carolina

35 4 p. 886-898
article
34 Positron emission tomography imaging of 5-hydroxytryptamine1B receptors in Parkinson's disease Varrone, Andrea

35 4 p. 867-875
article
35 Regional white matter hyperintensities: aging, Alzheimer's disease risk, and cognitive function Birdsill, Alex C.

35 4 p. 769-776
article
36 Resting state functional connectivity alterations in primary lateral sclerosis Agosta, Federica

35 4 p. 916-925
article
37 SLC1A2 rs3794087 does not associate with essential tremor Ross, Jay P.

35 4 p. 935.e9-935.e10
article
38 Tissue transglutaminase in Alzheimer's disease – facts and fiction: a reply to “Tissue transglutaminase is a biochemical marker for Alzheimer's disease” Wolf, Johannes

35 4 p. e5-e9
article
39 Tissue transglutaminase is a biochemical marker for Alzheimer's disease Wilhelmus, Micha M.M.

35 4 p. e3-e4
article
40 Triggering receptor expressed on myeloid cells 2 variant is rare in late-onset Alzheimer's disease in Han Chinese individuals Yu, Jin-Tai

35 4 p. 937.e1-937.e3
article
                             40 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands